Literature DB >> 30961533

Modified balloon-stent kissing technique avoid side-branch compromise for simple true bifurcation lesions.

Wen-Bo Qu1, Wei Zhang1, Jun-Yan Liu1, Fan Zhang1, Shuai-Nan Mu1, Sheng-Ming Zhang1, Hao Tang1, Xi-Qian Liu1, Xue-Qi Li2, Bing-Chen Liu3.   

Abstract

BACKGROUND: Coronary bifurcation remains one of the most challenging lesion subsets in interventinal cardiology. Provisional stenting (PS) is the dominate technique for bifurcation lesions, but the key problem is the deterioration of side branch. Balloon-stent kissing technique (BSKT) as a new systematic approach which is based on modified jailed balloon technique is applied to improve the procedure success. In our center, we proposed a modified balloon-stent kissing technique(M-BSKT), which routine usage of proximal optimizing technique (POT) after rewiring was added as an optimization step to BSKT. Thus, whether M-BSKT for addressing simple true coronary bifurcation lesions can provide more benefits in intra-operation effect and long term outcomes is still unknown.
METHODS: A cohort of 120 consecutive patients underwent Percutaneous Coronary Intervention (PCI) with simple true coronary bifurcation lesions satisfied the criteria were included in this retrospective, single-center registry. To assemble a cohort with similar baseline characteristics, a 1:1 propensity-matched score was used. The primary outcomes were the rate of device and procedural success, the situation of side branch (SB) after main vessel (MV) inflation and the complications during intra-operative. The secondary outcomes were the clinical prognosis at 12 months such as rehospitalization for unstable angina and MACEs.
RESULTS: Before propensity matching, there were no significant differences in primary and secondary outcomes between two groups. After propensity-matched was used, 68 patients with similar propensity scores were included. At immediate procedural, M-BSKT was associated with a lower risk of SB deterioration and the application of final kissing balloon inflation (FKBI)[P = 0.036]. For ACS patients, besides the significant differences of immediate SB deterioration [P = 0.014] and FKBI application [P = 0.033], the incidence of TIMI flow< 3 in the PS was statistically significant higher than M-BSKT [P= 0.042]. The prognosis at 12 months such as rehospitalization for unstable angina and MACEs were similar for two groups [P = 0.613].
CONCLUSION: These observations prove that the M-BSKT enables side branch to be better protected in simple true bifurcation lesions, by a narrow margin. It may improve the angiographic outcomes about side branch deterioration and final kissing balloon performing compared with PS, especially in ACS patients. However, long-term clinical outcomes did not differ between patients treated for M-BSKT and PS at 12 months.

Entities:  

Keywords:  Acute coronary syndrame; Bifurcation lesions; Modified balloon-stent kissing technique; Percutaneous coronary intervention; Provisional stenting; Side branch deterioration

Mesh:

Year:  2019        PMID: 30961533      PMCID: PMC6454702          DOI: 10.1186/s12872-019-1052-0

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


Background

Coronary bifurcations are frequent and account for approximately 20% of all percutaneous coronary interventions [1]. Nonetheless,they represent one of the remaining challenges in interventional cardiology and the uniform strategy is still the subject of substantial debate in terms of a lower procedural success rate,a higher risk of procedural complications, and increasing rates of long-term adverse cardiac events [2]. During stent implantation, provisional stenting (PS) was often performed, where a conventional guide wire was inserted to the side branch (SB) before implanting stent to the main vessel (MV), if it wasn’t effective, then the SB could be treated. It has been widely accepted as the gold standard for its lower risks of major adverse cardiac events (MADEs), death, myocardial infarction (MI), and target vessel revascularization (TVR) in the majority of bifurcation lesions [3-11]. Whereas, simple strategy may shift the carina to the SB and induce a stenosis after stenting of MV. Major SB occlusion after MV stenting is one of the most serious complications closely associated with cardiac death and MI, and it may be the major reason why operators prefer more aggressive strategy in the bifurcation lesions [12-15]. Therefore, to prevent from carina displacement—the basic mechanism of side branch compromise during bifurcation percutaneous coronary intervention, several novel stenting systems for bifurcation lesions have been developed [16, 17]. The main purpose of this study was to perform a novel SB protection technique called Modified balloon-stent kissing technique (M-BSKT), which was based on balloon-stent kissing technique that was first proposed by Jin Z [18]. Routine usage of proximal optimizing technique (POT) after rewiring could make the malapposition in the stented MV segment completely corrected while maintaining perfect arterial circularity and achieving effective modification of physiological anatomy [19]. With this improvement, we modified balloon-stent kissing technique and discussed the advantage compared to other SB protection techniques such as PS.

Methods

Study population

From January 2015 to July 2017, a cohort of 120 consecutive patients who defined as true bifurcation lesions undergoing PCI were collected at The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. All the patients enrolled in our study population were patients with simple true bifurcation lesions (excluding the complex bifurcation lesions [20]). The study was approved by the institutional review board, and informed consents for participation in the trial were obtained from all patients. Data collection and monitoring were performed by an independent third-party contract research organization. The executive committee met regularly in person to monitor all aspects of the conduct of the trial.

Inclusion criteria

Patients were eligible for the studies if they were 18 to75 years old with true coronary bifurcation lesions undergoing PCI The true bifurcation lesion consisted at least one major SB, bifurcation classifications were made according to Medina classification [21]. Medina 1,1,1 1,0,1 and 0,1,1 coronary bifurcation lesions with an SB diameter ≥ 2.0 mm based on visual estimation were included in the training and study groups

Exclusion criteria

The bifurcation lesion was categorized as complex bifurcation lesions according to the DEFINITION [20], defined as Medina 1,1,1and 0,1,1 coronary bifurcation lesions with each major criterion (left main vessel with ostial SB lesion length ≥ 10 mm and diameter stenosis (DS) ≥ 70%; non-left main vessel with ostial SB lesion length ≥ 10 mm and DS ≥ 90%) plus any 2 minor criteria (moderate to severe calcification; multiple lesions; bifurcation angle >45; main vessel RVD<2.5mm; thrombus-containing lesions; MV lesion length ≥25mm) Subject with renal failure (serum creatinine > 2.0 mg/dl) Subject exhibited severe left ventricular dysfunction (left ventricular ejection fraction < 35%) Subject with a serious comorbidity or with life expectancy < 1 year Subject exhibited contraindications to aspirin or clopidogrel

Procedure and outcomes

According to the ratio of 1:2, we randomly gathered patients with simple true bifurcation lesions to M-BSKT (n = 40) and PS (n = 80). The study patients in both groups received the same routine preparation with antiplatelet and antithrombotic medications based on the current guidelines. Coronary angioplasty was performed in conventional manner, and the interventional strategy and instrumentation used were at the discretion of the interventional cardiologists. Decisions on treatment strategy for bifurcation lesions were attempted according to the randomization process by individual operators.

Provisional stenting (jailed wire) technique

The recommended strategy is to wire in both MV and SB, while the lesion preparation is made at the operator’s discretion. The MV is stented with jailed wire protecting in SB. Proximal Optimization Technique (POT) is mandated to achieve good apposition of the proximal MV stent after the SB is rewired with or without rescue final kissing (Indications are shown below). The wire in SB will not be removed until the POT is completed.

Modified balloon-stent kissing technique

The initial technique has been detailed in previous study [18]. The M-BSKT used at our institution is detailed in Fig. 1 and shown angiographically in Fig. 2: To be brief, vessel wiring and lesion preparation are the same as the jailed wire technique. A balloon that is appropriately sized to approximate or smaller than the reference vessel diameter of SB (generally 1.5–2.5 mm) is advanced into the SB. A stent is then advanced into correct position over the target lesion in the MV. Adequate length of balloon is advanced into SB to project the ostium. Then the jailed SB balloon is first inflated to low pressure (6-8 atm), meanwhile, the stent in MV is deployed to nominal pressure (8-10 atm)(Fig. 2b-c). The SB balloon is removed and the wire remains in SB. The stent balloon is then fully expanded to moderate or high pressure as clinically indicated for the optimization of the stent full expansion at the distal MV, and to correct any stent deformation as a result of the SB balloon inflation (Fig. 2d). If the SB is not compromised, the SB will be rewired followed by POT (Fig. 2e) that achieve effective modification of physiological anatomy. Final result was good in showing case (Fig. 2f).
Fig. 1

The details of modified balloon-stent kissing technique. BSKI: balloon-stent kissing inflation; MB: main branch; SB: side branch; POT: proximal optimization technique

Fig. 2

Coronary angiography illustrating the modified balloon-stent kissing technique. a: The angiogram demonstrates severe stenosis at simple true bifurcation segment (Medina 1,1,1). b: A balloon that is sized to the reference vessel diameter of SB (2.5 mm) is advanced into the SB. A stent (3.5 mm) is then advanced into correct position over the target lesion in the MV. c: The jailed SB balloon is inflated to 6 atm, meanwhile, the stent in MV is deployed to 8 atm. d: The stent balloon is fully expanded to 12 atm. e: The SB is rewired followed by POT (4.0 mm non-compliant balloon). f: No residual stenosis both in MV and SB in final angiogram

The details of modified balloon-stent kissing technique. BSKI: balloon-stent kissing inflation; MB: main branch; SB: side branch; POT: proximal optimization technique Coronary angiography illustrating the modified balloon-stent kissing technique. a: The angiogram demonstrates severe stenosis at simple true bifurcation segment (Medina 1,1,1). b: A balloon that is sized to the reference vessel diameter of SB (2.5 mm) is advanced into the SB. A stent (3.5 mm) is then advanced into correct position over the target lesion in the MV. c: The jailed SB balloon is inflated to 6 atm, meanwhile, the stent in MV is deployed to 8 atm. d: The stent balloon is fully expanded to 12 atm. e: The SB is rewired followed by POT (4.0 mm non-compliant balloon). f: No residual stenosis both in MV and SB in final angiogram The SB is not further treated both in PS and M-BSKT groups unless there is threatened SB closure, severe ostial pinching of SB (> 90%), TIMI flow grade decrease in SB, or SB dissection greater than type A. If one of these criteria exists, the SB will be rewired and a final kissing balloon inflation (FKBI) will be undertaken with anatomically appropriate sizing for each vessel. A bailout stent in side branch is implanted only in case of dissection or significant flow impairment after FKBI. Finally, the re-POT strategy is mandated to achieve optimization apposition of the proximal MV stent. In addition, it needs to be emphasized that the MV stent should be sized according to the distal main vessel diameter to prevent irreversible carina shift, and the non-compliant balloon should be chosen for POT and sized according to the Murray’s law. At postprocedure, all patients received aspirin (100 mg/d) indefinitely, and clopidogrel (75 mg/d) would be recommended for at least 12 months. The administration of glycoprotein IIb/IIIa inhibitors was performed at the discretion of the operator.

Follow-up

Clinical follow-up was performed by physicians via medical chart review or telephone interview at 12 months. Adverse events were monitored throughout the entire study period. Angiographic re-evaluation was planned after 1 year. The information of 120 patients was eventually collected.

Primary and secondary endpoint(s)

The primary endpoints of the study were the rates of device and procedural success (lesion success without the occurrence of in-hospital major adverse cardiac events (MACEs) such as death, myocardial infarction (MI), emergent coronary artery bypass graft (CABG), clinically driven target lesion revascularization (TLR)), the total numbers of FKBI used (because of the SB ostial pinching ≥90% and the TIMI flow< 3 after the MB stenting), the incidence of SB occlusion(after MV stent inflation) and the probability of balloons and wires damaged or even broken during their removal. Secondary endpoints were a composite of the rehospitalization rate due to angina pectoris and MACEs at 12 months (defined as cardiac death, MI, and any TLR by PCI or CABG).

Statistical analysis

Descriptive statistics were presented as percentages for categorical variables. Baseline characteristics were compared using a Chi-square or Fisher exact test for categorical variables and a Mann-Whitney U test for continuous variables because of they not compared to normal distribution. For non-normally distributed variables, median and IQR were used. In addition to conventional multivariate analysis, we constructed a propensity score within a ± 0.2 caliper range for adjustment and matching using R package matching. Matched categorical and continuous variables were presented same as before. A P value of < 0.05 was considered to represent a statistically significant difference. All the statistical models were performed using R Programming Language.

Results

Baseline characteristics

Between January 2015 and July 2017,a total of 120patients with true coronary bifurcation lesions satisfied all inclusion/exclusion criteria undergoing PCI were enrolled and ramdomly assigned to M-BSKT(n = 40) and PS(n = 80). All patients were followed up for 12 months. There were no significant differences between the two groups for patient’s baseline clinical characteristics (Table 1) and lesion characteristics (Table 2),respectively.
Table 1

Baseline Characteristics

pre propensity-matched analysispost propensity-matched analysis
M-BSKTPSP ValueM-BSKTPSP Value
n = 40n = 80n = 34n = 34
Male30 (75%)62 (77.5%)0.93925 (73.5%)26 (76.5%)1
Hypertension28 (70%)42 (52.5%)0.10222 (64.7%)21 (61.8%)1
Diabetes Mellitus14 (35%)19 (23.8%)0.20210 (29.4%)10 (29.4%)1
Hyperlipidemia14 (35%)25 (31.3%)0.83613 (38.2%)10 (29.4%)0.608
Smoker15 (37.5%)39 (48.8%)0.33114 (41.2%)20 (58.8%)0.225
prior CABG1 (2.5%)00.33300NS
prior PCI6 (15%)14 (17.5%)0.9315 (14.7%)3 (8.8%)0.709
prior MI4 (10%)9 (22.5%)12 (5.9%)1 (2.9%)1
Chronic kidney disease1 (2.5%)2 (2.5%)11 (2.9%)01
Diagnosis at PCI
 STEMI3 (7.5%)11 (13.8%)0.4642 (5.9%)4 (11.7%)0.577
 NSTEMI9 (22.5%)22 (27.5%)6 (17.6%)8 (23.5%)
 Angina28 (70%)47 (58.8%)26 (76.5%)22 (64.7%)
Age6259.50.25562590.368
 IQR121313.510.5
TNI0.010.010.4870.010.010.533
 IQR0.0680.1870.0210.21
CK-MB14150.39714150.1
 IQR4.256.2545.75

Data are presented as median (interquartile range) for continuous variables and n (%) for categorical variables. Chi-square or Fisher exact test for categorical variables and a Mann-Whitney U test for continuous variables. CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; MI, myocardial infarction; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; TNI, Troponin I; CK-MB, Creatine Kinase-MB

Table 2

Lesion characteristics

pre propensity-matched analysispost propensity-matched analysis
M-BSKTPSP ValueM-BSKTPSP Value
n = 40n = 80n = 34n = 34
LocationLAD-D127 (67.5%)56 (70.0%)0.48126 (76.5%)24 (70.6%)0.741
LAD-LCX7 (17.5%)13 (16.3%)6 (17.6%)8 (23.5%)
LCX-OM2 (5.0%)7 (8.8%)2 (5.9%)1 (2.9%)
LAD-RI3 (7.5%)1 (1.3%)01 (2.9%)
RCA-PD1 (2.5%)3 (3.8%)00
Medina1.1.131 (77.5%)63 (78.8%)126 (76,5%)25 (73.5%)0.846
1.0.15 (12.5%)9 (11.25%)4 (11.8%)6 (17.6%)
0.1.14 (10.0%)8 (10.0%)4 (11.8%)3 (8.8%)

Values are n(%). LAD, left anterior descending; D, diagonal artery; LCX, left circumflex; OM,obtuse marginal branch; RCA,right coronary artery; RI, ramus intermedius artery; PD, posterior descending artery

Baseline Characteristics Data are presented as median (interquartile range) for continuous variables and n (%) for categorical variables. Chi-square or Fisher exact test for categorical variables and a Mann-Whitney U test for continuous variables. CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; MI, myocardial infarction; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; TNI, Troponin I; CK-MB, Creatine Kinase-MB Lesion characteristics Values are n(%). LAD, left anterior descending; D, diagonal artery; LCX, left circumflex; OM,obtuse marginal branch; RCA,right coronary artery; RI, ramus intermedius artery; PD, posterior descending artery

Procedural outcomes

The immediate procedural and clinical outcomes are displayed in Table 3. The operation successful rate was 100% in each group. The study showed no statistically significant clinical impact of SB deterioration [M-BSKT n = 7(17.5%); PS n = 28(35.0%); P = 0.076] in 2 groups (Fig. 3a). The rates of SB TIMI flow < 3 were 7.5% and 15%[P = 0.38], severe SB ostial pinching (≥90%) were 10% and 17.5% [P = 0.412], in the M-BSKT versus the PS groups, respectively. Besides, 2 patientsSB occluded immediately in PS, and the other patients whose SB damaged underwent FKBI [M-BSKT n = 7(17.5%); PS n = 26(32.5%); P = 0.129] (Fig. 3b). SB flow was restored spontaneously in 2 groups [M-BSKT n = 7(17.5%); PS n = 23(28.8%); P = 0.263]. The use of bailout SB stenting was 2.5% of the PS group [n = 2; P = 0.552]. Compared with M-BSKT, 5 patientsSB in PS were inevitable occluded despite all SB had jailed wire, even though 3 of them underwent FKBI [M-BSKT n = 0; PS n = 5(6.3%)); P = 0.168]. All the wires and balloons were not entrapped during the operations.
Table 3

Outcomes

pre propensity-matched analysispost propensity-matched analysis
M-BSKTPSP ValueM-BSKTPSP Value
n = 40n = 80n = 34n = 34
immediate procedural and clinical outcomes
 Device and procedural success40 (100.0%)80 (100.0%)134 (100.0%)34 (100.0%)1
 Main-vessel TIMI flow 3 after procedure40 (100.0%)80 (100.0%)134 (100.0%)34 (100.0%)1
 Side-branch deterioration7 (17.5%)28 (35.0%)0.0766 (17.6%)15 (44.1%)0.036
  SB TIMI flow <33 (7.5%)12 (15%)0.383 (8.8%)5 (14.7%)0.709
  SB ostial pinching≥90%4 (10%)14 (17.5%)0.4123 (8.8%)10 (29.4%)0.062
  SB occlusion immediately02 (2.5%)0.55200NS
 rescue FKBI7 (17.5%)26 (32.5%)0.1296 (17.6%)15 (44.1%)0.036
 Bailout stenting02 (2.5%)0.55200NS
 Revascularization7 (17.5%)23 (28.8%)0.2636 (17.6%)13 (38.2%)0.104
 SB loss05 (6.3%)0.16802 (5.9%)0.492
 Wire or balloon damaged00NS00NS
The prognosis after 12 months
 Stable condition37 (92.5)73 (91.3%)0.55831 (91.2%)32 (94.1%)0.613
 Rehospitalization for unstable angina3 (7.5%)4 (5.0%)3 (8.8%)1 (2.9%)
 MACEs03 (3.8%)01 (2.9%)

Values are n(%).TIMI, thrombolysis in myocardial infarction; FKBI, final kissing-balloon inflation; MACEs, major adverse cardiac events

Fig. 3

a The Ratio of SB deterioration. The P-values of the incidence of immediate SB deterioration between the 2 groups (pre-PSM and post-PSM). b The Ratio of rescue FKBI application. The P-values of the rescue FKBI application between the 2 groups (pre-PSM and post-PSM). PSM: propensity-matched analysis. FKBI: final kissing balloon inflation. * means P < 0.05

Outcomes Values are n(%).TIMI, thrombolysis in myocardial infarction; FKBI, final kissing-balloon inflation; MACEs, major adverse cardiac events a The Ratio of SB deterioration. The P-values of the incidence of immediate SB deterioration between the 2 groups (pre-PSM and post-PSM). b The Ratio of rescue FKBI application. The P-values of the rescue FKBI application between the 2 groups (pre-PSM and post-PSM). PSM: propensity-matched analysis. FKBI: final kissing balloon inflation. * means P < 0.05

Clinical outcomes at 12 months

Long-term clinical outcomes did not differ between patients treated with M-BSKT and PS at 12 months [P = 0.558]. The cumulative rehospitalization for unstable angina was similar between M-BSKT [3(7.5%)] and PS [n=4(5.0%)]. The cumulative 1-year MACEs was only occurred in PS group [n=3(3.8%)] (Table 3 and Fig. 4).
Fig. 4

Clinical outcomes at 12 months. PSM = propensity-matched analysis. Before PSM, 12 months clinical outcomes about rehospitalization for unstable angina and MACEs did not differ between patients treated with M-BSKT and PS. The prognosis at 12 months were similar between 2 groups after PSM

Clinical outcomes at 12 months. PSM = propensity-matched analysis. Before PSM, 12 months clinical outcomes about rehospitalization for unstable angina and MACEs did not differ between patients treated with M-BSKT and PS. The prognosis at 12 months were similar between 2 groups after PSM

Propensity score matching

We conducted propensity score matching by using R package matching and matched patients within a ± 0.2 caliper range. The following 15 preoperative variables were considered in the stepwise logistic regression multivariable analysis: male, age, hypertension, diabetes mellitus, hyperlipidemia, smoke, prior CABG, prior PCI, prior MI, chronic kidney disease, diagnosis at PCI, Troponin I (TNI), Creatine Kinase-MB (CK-MB), the location of bifurcation lesions and Medina classification. A matched pair of 34 M-BSKT and 34 PS patients was identified. Patient characteristics were well matched between the 2 groups in Tables 1 and 2.After propensity score matching, the incidence of immediate SB deterioration was significant lower in M-BSKT than PS [M-BSKT n = 6(17.6%); PS n = 15(44.1%); P = 0.036] (Table 3; Fig. 3a). Among them, there was no distinction about TIMI flow deterioration [M-BSKT n = 3(8.8%); PS n = 5(14.7%);P = 0.709] and ostial pinching [M-BSKT n = 3(8.8%);PS n = 10(29.4%);P = 0.062] between two groups. The application of rescue FKBI in M-BSKT was significant lower than PS [M-BSKT n = 6(17.6%); PS n = 15(44.1%); P = 0.036](Fig. 3b). In spite of all the patients who defined as SB deterioration underwent FKBI, 2 patientsSB were lost in PS group [n = 2(5.9%), P = 0.492]. The prognosis at 12 months such as rehospitalization for unstable angina [M-BSKT n = 3(8.8%); PS n = 1(2.9%)] and MACEs [M-BSKT n = 0; PS n = 1(2.9%)] were similar between the two groups [P = 0.613] showed in Table 3 and Fig. 4.

Subgroup analysis of acute coronary syndrome (ACS)

Baseline Characteristics and procedural outcomess of patients with acute coronary syndrome in the two groups were reanalyzed. The ACS patients were all recruited in two subgroups; 1) M-BSKT group (n = 12) and 2) PS group (n = 33). There were no significant differences in baseline clinical characteristics between the two groups. Angiographic and procedural characteristics of the two groups are shown in Table 4. The immediate SB deterioration in the PS group [n = 17(51.5%)] was significant higher compared to M-BSKT group [n = 1(8.3%);P = 0.014] (Fig. 5a). All situations of SB deterioration were not identical between two groups (Fig. 5c). The PS group displayed a higher (P = 0.042) rate [n = 10(30.3%)] of SB TIMI flow< 3 than M-BSKT. FKBI was more frequently performed in PS group [n = 15(45.5%)] than M-BSKT group [n = 1(8.3%);P = 0.033] (Fig. 5b). Despite the SB loss in two groups showed no difference, there were 4 (12.1%) patients in ACS patients, which made a big proportion of all patients.
Table 4

immediate procedural and clinical outcomes of ACS patients

patients with acute coronary syndrome
M-BSKTPSP Value
n = 12n = 33
immediate procedural and clinical outcomes
 Device and procedural success12 (100.0%)33 (100.0%)1
 Main-vessel TIMI flow3 after procedure12 (100.0%)33 (100.0%)1
 Side-branch deterioration1 (8.3%)17 (51.5%)0.014
  SB TIMI flow <3010 (30.3%)0.042
  SB ostial pinching≥90%1 (8.3%)5 (15.2%)1
  SB occlusion immediately02 (6.1%)1
 rescue FKBI1 (8.3%)15 (45.5%)0.033
 Bailout stenting01 (3.0%)1
 Revascularization1 (8.3%)13 (39.4%)0.07
 SB loss04 (12.1%)0.561
 Wire or balloon damaged00NS

Values are n(%).TIMI, thrombolysis in myocardial infarction; FKBI, final kissing-balloon inflation

Fig. 5

immediate procedural and clinical outcomes of ACS patients. Subgroup analysis of ACS patients: (a) The ratio of immediate SB deterioration (b) The ratio of rescue FKBI application (c) The ratio of the each scenes of SB deterioration between the 2 groups . * means P < 0.05

immediate procedural and clinical outcomes of ACS patients Values are n(%).TIMI, thrombolysis in myocardial infarction; FKBI, final kissing-balloon inflation immediate procedural and clinical outcomes of ACS patients. Subgroup analysis of ACS patients: (a) The ratio of immediate SB deterioration (b) The ratio of rescue FKBI application (c) The ratio of the each scenes of SB deterioration between the 2 groups . * means P < 0.05

Discussion

The present study focus on clinical outcomes between M-BSKT and PS techniques for simple true bifurcation lesions stratified the criteria. The principal findings in this study are as follows: 1) In general, M-BSKT was similar to PS in every aspects except the damage of SB and the rate of FKBI application. 2) In ACS patients, performing M-BSKT was a significant factor to protect SB, especially in preventing the deterioration of TIMI flow and reducing the application of FKBI. Although the ESC guidelines strongly recommends provisional SB stenting taking into consideration not only immediate but also long-term results of this strategy [22], abrupt closure of the SB may occur after MV stent implantation [12-14]. Meanwhile, SB occlusion occurred more frequently in patients with true bifurcation lesions than in those with non-true bifurcation lesions [23]. In the present clinical trial, the final outcomes of provisional stenting of bifurcation lesions were not associated with significant improvement [15, 24]. In our study, we compared the safety and efficacy of PS and M-BSKT during the treatment of some especial bifurcation lesions. It adopted the criteria of true bifurcation lesions and eliminated the complex bifurcation lesions established by Chen [20]. Based on previous researches, we eliminated complex bifurcation lesions that may get the maximum benefit from 2-stent techniques. Since a proportion of patients with a severe big SB lesions (simple true bifurcation lesions) would remain ischemic after MV stenting, the jailed SB wire or balloon facilitated rewiring of the SB by widening the angle between the MV and SB and prevented SB occlusion. This experiment using SB ostial pinching≥90% by angiography as an indication for SB intervention reduced the unnecessary intervention of SB in the maximum limit. Meanwhile, a bailout stent in side branch was implanted only in case of dissection or significant flow impairment after FKBI. The construction of the classical stent did not take into consideration vessel tapering in bifurcation lesions and resulted in carina and plaque shift—the main mechanisms of SB compromise [15]. However, the M-BSKT consists of leaving a dilated balloon in SB while implanting a stent in the MV. It impacts less on the bifurcation segment by means of limiting carina and plaque shift towards to SB, which are two major factors responsible for SB compromise [18]. Yohei Numasawa [17] evaluated the configuration of true bifurcation lesion after stent implantation using the jailed balloon technique by three-dimensional optical frequency domain imaging (OFDI) which provided clearer and higher resolution images. It was already indicated clearly that there were no signs of plaque or carina shift into the SB. However, there was little data to support the advantage of this technique. In this case, we clustered data from 2 groups about the SB ostial deteriorations and found out all deteriorations were slightly less when applying M-BSKT than PS. The advantage of M-BSKT that balloon inflated between the time from the stent located to inflated could protect SB more effective in theory. Based on the date and trends we observed, the implementation of M-BSKT had no significant differences regarding to SB protection in the 2 study groups, but a trend towards superior clinical results in patients treated with M-BSKT. So the propensity score matching was used to identify the diversity between the 2 techniques. Baseline features were well balanced among M-BSKT patients versus PS patients. We noted the difference in immediate procedural and clinical outcomes between the 2 groups in the matched cohort. When propensity score matching was adopted, the effect of SB protection revealed the superior technical advantages of M-BSKT comparing with PS. As a result, the rate of SB flow deterioration and dissection after MV stenting at once was higher in PS. Because of cardiac death or myocardial infarction occurred more frequently in patients with SB occlusion [14], it is conceivable to infer that the inflated balloon of the SB provides a high degree of SB protection in immediate procedural. According to research results available, jailed wire in SB was associated with the recovery of the occluded SB [14]. What’s more, it indicated that M-BSKT used as a rescue procedure to keep the SB open was superior to PS on the basis of technological advantages, once the branch was occluded. This led to significantly reduced proximal deformation with related malapposed struts and reduced rate of SB ostial stenosis. Jailed balloon in SB could be inflated and FKBI could be applied, as long as the damage of SB flow happened accidentally. In some respect, MB restenosis was higher in the routine FKBI group due to the potential distortion of the MB stent strut [25]. On this premise, it is recommended to avoid deploying FKBI technique. The hypothesis that M-BSKT could decrease the proportion of FKBI implement during operation was justified in this study. Interestingly, when we conducted subgroup analysis of patients with acute coronary syndrome, the advantages of M-BSKT were showed prominently. It just made a clarity conclusion that M-BSKT may provide more protection of SB. Patients with ACS are likely to have multiple vulnerable plaques that are liable to rupture or shift [26, 27]. According to ACS patients with special bifurcation lesions, M-BSKT may limit thrombosis and plaque shift towards to SB more effectively, which avoid the impact on TIMI flow and reduce the application of FKBI. As we all know, POT consists of an inflating balloon to the MV reference diameter which makes the malapposition in the stented MV segment completely corrected while maintaining perfect arterial circularity [19]. Though high rates of restenosis and stent thrombosis were still often observed after stenting, POT would provide potential benefits such as partially reducing malapposition and achieving effective modification of physiological anatomy [19, 28]. In this study, POT was used as a favourable step to modify BSKT in order to reduce severe coronary flow problems. Irrespective of propensity score matching, the findings of 1 year clinical follow-up were similar between the 2 techniques. However, wether M-BSKT will play a safe and effective role for a longer period of time is still unknown. Evaluation of long clinical outcomes of two stent percutaneous intervention strategy for treatment of coronary bifurcation lesions offered advantage over PS, simultaneously [11]. Therefore, with our present data, M-BSKT elicited more advantages than PS applied to simple true bifurcation lesions in the operation procedure.

Limitations

The first and foremost limitation of this study was that it did not involve a significant population. Also, visual estimation of the diameters was used in this study to dedicate bifurcations, rather than quantitative coronary measurement. It may be not precise for the selection of clinically relevant SB. Previous studies suggested that angiographic visual assessment of jailed SB lesions tended to overestimate the severity of jailed SB lesions compared to functional assessment by FFR. Regrettably, there was no application of FFR in this study. Differences in the angiographic assessment of SB lesion severity can affect the treatment strategy for bifurcation lesions. This manuscript used SB ostial pinching≥90% by angiography as indication for SB intervention that was reduced the unnecessary intervention of SB in the maximum limit. Of note, there was a discrepancy between the assessment of the ischemia-inducibility and plan-to-treat. These variable and discrepant values might have influenced the differences of SB intervention between two groups. Although bifurcation angle was regarded as one of the important factors for bifurcation PCI, we excluded it from the scope of criteria, which may influence the SB-occlusion rate. In addition, fractional flow reserve for evaluating the significance of SB ostial lesions wasn't used before and after the procedure. Because randomization may interfere with the chosen of different bifurcations, the simple true bifurcations of the right coronary artery were rarely contained in our study.

Conclusions

We demonstrated that, for patients with coronary simple true bifurcation lesions, M-BSKT provides preferable outcomes comparing with the PS after propensity score matching. Because of the existence of vulnerable plaques in ACS patients exist, the advantages of M-BSKT were showed prominently. Our case reported that it appeared to be a reasonable and suitable strategy to reduce the deterioration of SB and the application of FKBI when MV stent was inflated during the operation. Although M-BSKT has been performed, its long-term impact on patients' outcomes cannot be ascertained based on current studies and requires further investigation on the correlation between BSKT and clinical outcomes.
  28 in total

1.  Final proximal post-dilatation is necessary after kissing balloon in bifurcation stenting.

Authors:  Nicolas Foin; Gioel G Secco; Liviu Ghilencea; Rob Krams; Carlo Di Mario
Journal:  EuroIntervention       Date:  2011-09       Impact factor: 6.534

2.  Comparative Analysis of Sequential Proximal Optimizing Technique Versus Kissing Balloon Inflation Technique in Provisional Bifurcation Stenting: Fractal Coronary Bifurcation Bench Test.

Authors:  Gérard Finet; François Derimay; Pascal Motreff; Patrice Guerin; Paul Pilet; Jacques Ohayon; Olivier Darremont; Gilles Rioufol
Journal:  JACC Cardiovasc Interv       Date:  2015-08-24       Impact factor: 11.195

3.  [A new classification of coronary bifurcation lesions].

Authors:  Alfonso Medina; José Suárez de Lezo; Manuel Pan
Journal:  Rev Esp Cardiol       Date:  2006-02       Impact factor: 4.753

4.  Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study.

Authors:  Antonio Colombo; Ezio Bramucci; Salvatore Saccà; Roberto Violini; Corrado Lettieri; Roberto Zanini; Imad Sheiban; Leonardo Paloscia; Eberhard Grube; Joachim Schofer; Leonardo Bolognese; Mario Orlandi; Giampaolo Niccoli; Azeem Latib; Flavio Airoldi
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

5.  Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study.

Authors:  Miles W Behan; Niels R Holm; Adam J de Belder; James Cockburn; Andrejs Erglis; Nicholas P Curzen; Matti Niemelä; Keith G Oldroyd; Kari Kervinen; Indulis Kumsars; Paal Gunnes; Rodney H Stables; Michael Maeng; Jan Ravkilde; Jan Skov Jensen; Evald H Christiansen; Nina Cooter; Terje K Steigen; Saila Vikman; Leif Thuesen; Jens Flensted Lassen; David Hildick-Smith
Journal:  Eur Heart J       Date:  2016-05-08       Impact factor: 29.983

6.  Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).

Authors:  Shao-Liang Chen; Imad Sheiban; Bo Xu; Nigel Jepson; Chitprapai Paiboon; Jun-Jie Zhang; Fei Ye; Teugh Sansoto; Tak W Kwan; Michael Lee; Ya-Ling Han; Shu-Zheng Lv; Shang-Yu Wen; Qi Zhang; Hai-Chang Wang; Tie-Ming Jiang; Yan Wang; Liang-Long Chen; Nai-Liang Tian; Feng Cao; Chun-Guang Qiu; Yao-Jun Zhang; Martin B Leon
Journal:  JACC Cardiovasc Interv       Date:  2014-10-15       Impact factor: 11.195

7.  Coronary bifurcation lesions: is less more?

Authors:  Johan Bennett; Christophe Dubois
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

8.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Philippe Kolh; Stephan Windecker; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Çetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Miguel Sousa Uva; Stephan Achenbach; John Pepper; Anelechi Anyanwu; Lina Badimon; Johann Bauersachs; Andreas Baumbach; Farzin Beygui; Nikolaos Bonaros; Marco De Carlo; Christi Deaton; Dobromir Dobrev; Joel Dunning; Eric Eeckhout; Stephan Gielen; David Hasdai; Paulus Kirchhof; Heyman Luckraz; Heiko Mahrholdt; Gilles Montalescot; Domenico Paparella; Ardawan J Rastan; Marcelo Sanmartin; Paul Sergeant; Sigmund Silber; Juan Tamargo; Jurrien ten Berg; Holger Thiele; Robert-Jan van Geuns; Hans-Otto Wagner; Sven Wassmann; Olaf Wendler; Jose Luis Zamorano
Journal:  Eur J Cardiothorac Surg       Date:  2014-08-29       Impact factor: 4.191

9.  An angiographic tool for risk prediction of side branch occlusion in coronary bifurcation intervention: the RESOLVE score system (Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion).

Authors:  Kefei Dou; Dong Zhang; Bo Xu; Yuejin Yang; Dong Yin; Shubin Qiao; Yongjian Wu; Hongbing Yan; Shijie You; Yang Wang; Zhenqiang Wu; Runlin Gao; Ajay J Kirtane
Journal:  JACC Cardiovasc Interv       Date:  2015-01       Impact factor: 11.195

10.  Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.

Authors:  Michael Maeng; Niels R Holm; Andrejs Erglis; Indulis Kumsars; Matti Niemelä; Kari Kervinen; Jan S Jensen; Anders Galløe; Terje K Steigen; Rune Wiseth; Inga Narbute; Pål Gunnes; Jan Mannsverk; Oliver Meyerdierks; Svein Rotevatn; Kjell Nikus; Saila Vikman; Jan Ravkilde; Stefan James; Jens Aarøe; Antti Ylitalo; Steffen Helqvist; Iwar Sjögren; Per Thayssen; Kari Virtanen; Mikko Puhakka; Juhani Airaksinen; Evald H Christiansen; Jens F Lassen; Leif Thuesen
Journal:  J Am Coll Cardiol       Date:  2013-05-01       Impact factor: 24.094

View more
  2 in total

Review 1.  Percutaneous Coronary Intervention for Coronary Bifurcation Lesions: Latest Evidence.

Authors:  Sean Tan; John Ramzy; Sonya Burgess; Sarah Zaman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-08

Review 2.  Jailed balloons for side branch protection: a review of techniques and literature: Jailed balloons for side branch protection.

Authors:  Bilal Kabeer Khan; Muhammad Nasir Rahman; Javed Majid Tai; Osman Faheem
Journal:  AsiaIntervention       Date:  2020-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.